Lyudmila Bazhenova

34PUBLICATIONS
197CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMolecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 04, 2026
Characterizing Time Toxicity in Lung Cancer Clinical Trials: Development and Application of a Novel Time Burden Metric.

|Aug 17, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.

|May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1.

|Feb 13, 2026
Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study.

Pankaj Gupta, Kalpna Gupta, Travis Dockter

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.

Sonam Puri, Natasha B Leighl, Nofisat Ismaila

Pageof 6

Frequent Collaborators

10 joint publications

Nofisat Ismaila

8 joint publications

Janet Freeman-Daily

7 joint publications

Natasha B Leighl

6 joint publications

Balazs Halmos